Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CRANBROOK, British Columbia, Feb. 04, 2026 (GLOBE NEWSWIRE) -- DLP Resources Inc. (TSXV: DLP / OTCQB: DLPRF / FSE: J8C), based in Canada, focused on copper and molybdenum today announced that Ian...
-
BROOKFIELD, Conn., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Photronics, Inc. (Nasdaq:PLAB), a worldwide leader in photomask technologies and solutions, today announced the following upcoming investor...
-
AVENTURA, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Safe Pro Group Inc. (Nasdaq: SPAI) (“Safe Pro” or the “Company”), a developer of artificial intelligence (“AI”)-enabled defense, security, and...
-
GARDEN CITY, N.Y., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for...
-
PHILADELPHIA, Feb. 04, 2026 (GLOBE NEWSWIRE) -- AMPLIFY will host an exclusive, members-only Pennsylvania Association for Justice (PAJ) CLE, Adapt or Die: Running a Modern Law Firm Without Losing...
-
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Jim Zelter, President of Apollo Global Management, will participate in a fireside chat at the BofA Securities...
-
NORTHBOROUGH, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today announced that Don Young, President & Chief Executive Officer, and Grant...
-
BOSTON and NEW HAVEN, Conn., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Normunity, a clinical stage biotechnology company pioneering precision biologics, today announced that management will participate in...
-
PRINCETON, N.J., Feb. 04, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and...
-
CAMBRIDGE, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,...